vs
Cooper Companies (The)（COO）与Liberty Global Ltd.（LBTYA）财务数据对比。点击上方公司名可切换其他公司
Liberty Global Ltd.的季度营收约是Cooper Companies (The)的1.2倍（$1.2B vs $1.1B），Cooper Companies (The)净利率更高（7.9% vs -237.0%，领先244.9%），Liberty Global Ltd.同比增速更快（187.2% vs 4.6%），Liberty Global Ltd.自由现金流更多（$193.3M vs $149.9M），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs -20.4%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
自由全球有限公司是一家英荷美合资的跨国电信企业，注册地位于百慕大，在伦敦、阿姆斯特丹和丹佛均设有总部。公司旗下拥有英国自由全球控股有限公司、荷兰自由全球有限公司及美国自由全球公司三大主体，其中英国主体为上市实体。企业由自由媒体国际业务部与UnitedGlobalCom于2005年合并成立，在全球电信服务领域拥有深厚的行业积累。
COO vs LBTYA — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.2B |
| 净利润 | $84.6M | $-2.9B |
| 毛利率 | 61.1% | 66.8% |
| 营业利润率 | 13.2% | -8.6% |
| 净利率 | 7.9% | -237.0% |
| 营收同比 | 4.6% | 187.2% |
| 净利润同比 | -28.0% | -230.0% |
| 每股收益（稀释后） | $0.42 | $-8.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $964.7M | $1.2B | ||
| Q4 24 | $1.0B | $-1.4B | ||
| Q3 24 | $1.0B | $1.9B | ||
| Q2 24 | $942.6M | $1.9B | ||
| Q1 24 | $931.6M | $1.9B |
| Q4 25 | $84.6M | $-2.9B | ||
| Q3 25 | $98.3M | $-90.7M | ||
| Q2 25 | $87.7M | $-2.8B | ||
| Q1 25 | $104.3M | $-1.3B | ||
| Q4 24 | $117.5M | $2.2B | ||
| Q3 24 | $104.7M | $-1.4B | ||
| Q2 24 | $88.9M | $268.1M | ||
| Q1 24 | $81.2M | $510.0M |
| Q4 25 | 61.1% | 66.8% | ||
| Q3 25 | 65.3% | 67.5% | ||
| Q2 25 | 67.8% | 63.3% | ||
| Q1 25 | 68.4% | 65.6% | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 66.1% | 69.4% | ||
| Q2 24 | 67.0% | 68.5% | ||
| Q1 24 | 67.0% | 65.4% |
| Q4 25 | 13.2% | -8.6% | ||
| Q3 25 | 16.6% | -0.7% | ||
| Q2 25 | 18.4% | 2.3% | ||
| Q1 25 | 18.9% | 5.2% | ||
| Q4 24 | 19.5% | — | ||
| Q3 24 | 19.2% | 5.2% | ||
| Q2 24 | 17.2% | 1.0% | ||
| Q1 24 | 16.4% | 1.2% |
| Q4 25 | 7.9% | -237.0% | ||
| Q3 25 | 9.3% | -7.5% | ||
| Q2 25 | 8.7% | -220.1% | ||
| Q1 25 | 10.8% | -114.2% | ||
| Q4 24 | 11.5% | -158.9% | ||
| Q3 24 | 10.4% | -74.1% | ||
| Q2 24 | 9.4% | 14.3% | ||
| Q1 24 | 8.7% | 26.2% |
| Q4 25 | $0.42 | $-8.66 | ||
| Q3 25 | $0.49 | $-0.27 | ||
| Q2 25 | $0.44 | $-8.09 | ||
| Q1 25 | $0.52 | $-3.84 | ||
| Q4 24 | $0.59 | $6.15 | ||
| Q3 24 | $0.52 | $-3.95 | ||
| Q2 24 | $0.44 | $0.71 | ||
| Q1 24 | $0.41 | $1.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $2.2B |
| 总债务越低越好 | $2.5B | $7.8B |
| 股东权益账面价值 | $8.2B | $9.7B |
| 总资产 | $12.4B | $22.6B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.80× |
8季度趋势，按日历期对齐
| Q4 25 | $110.6M | $2.2B | ||
| Q3 25 | $124.9M | $1.7B | ||
| Q2 25 | $116.2M | $3.1B | ||
| Q1 25 | $100.9M | $2.0B | ||
| Q4 24 | $107.6M | $2.2B | ||
| Q3 24 | $109.7M | $3.3B | ||
| Q2 24 | $112.4M | $3.2B | ||
| Q1 24 | $135.2M | $2.8B |
| Q4 25 | $2.5B | $7.8B | ||
| Q3 25 | $2.4B | $7.8B | ||
| Q2 25 | $2.5B | $7.8B | ||
| Q1 25 | $2.5B | $8.2B | ||
| Q4 24 | $2.6B | $8.2B | ||
| Q3 24 | $2.6B | $14.9B | ||
| Q2 24 | $2.7B | $14.7B | ||
| Q1 24 | $2.7B | $14.8B |
| Q4 25 | $8.2B | $9.7B | ||
| Q3 25 | $8.4B | $12.7B | ||
| Q2 25 | $8.3B | $13.0B | ||
| Q1 25 | $8.1B | $12.6B | ||
| Q4 24 | $8.1B | $12.4B | ||
| Q3 24 | $7.9B | $18.7B | ||
| Q2 24 | $7.8B | $18.3B | ||
| Q1 24 | $7.7B | $18.4B |
| Q4 25 | $12.4B | $22.6B | ||
| Q3 25 | $12.4B | $25.4B | ||
| Q2 25 | $12.4B | $27.2B | ||
| Q1 25 | $12.2B | $26.0B | ||
| Q4 24 | $12.3B | $25.4B | ||
| Q3 24 | $12.1B | $41.8B | ||
| Q2 24 | $12.0B | $40.8B | ||
| Q1 24 | $12.0B | $40.6B |
| Q4 25 | 0.30× | 0.80× | ||
| Q3 25 | 0.29× | 0.61× | ||
| Q2 25 | 0.30× | 0.60× | ||
| Q1 25 | 0.31× | 0.65× | ||
| Q4 24 | 0.32× | 0.66× | ||
| Q3 24 | 0.33× | 0.80× | ||
| Q2 24 | 0.34× | 0.80× | ||
| Q1 24 | 0.35× | 0.80× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | $630.9M |
| 自由现金流经营现金流 - 资本支出 | $149.9M | $193.3M |
| 自由现金流率自由现金流/营收 | 14.1% | 15.7% |
| 资本支出强度资本支出/营收 | 9.2% | 35.5% |
| 现金转化率经营现金流/净利润 | 2.93× | — |
| 过去12个月自由现金流最近4个季度 | $433.7M | $-132.0M |
8季度趋势，按日历期对齐
| Q4 25 | $247.9M | $630.9M | ||
| Q3 25 | $261.4M | $301.8M | ||
| Q2 25 | $96.2M | $149.2M | ||
| Q1 25 | $190.6M | $129.2M | ||
| Q4 24 | $268.1M | $791.6M | ||
| Q3 24 | $207.5M | $449.5M | ||
| Q2 24 | $111.0M | $546.1M | ||
| Q1 24 | $122.7M | $245.7M |
| Q4 25 | $149.9M | $193.3M | ||
| Q3 25 | $164.5M | $-41.1M | ||
| Q2 25 | $18.1M | $-170.1M | ||
| Q1 25 | $101.2M | $-114.1M | ||
| Q4 24 | $128.1M | $712.9M | ||
| Q3 24 | $118.5M | $102.4M | ||
| Q2 24 | $36.9M | $256.8M | ||
| Q1 24 | $4.6M | $-105.1M |
| Q4 25 | 14.1% | 15.7% | ||
| Q3 25 | 15.5% | -3.4% | ||
| Q2 25 | 1.8% | -13.4% | ||
| Q1 25 | 10.5% | -9.7% | ||
| Q4 24 | 12.6% | -50.5% | ||
| Q3 24 | 11.8% | 5.3% | ||
| Q2 24 | 3.9% | 13.7% | ||
| Q1 24 | 0.5% | -5.4% |
| Q4 25 | 9.2% | 35.5% | ||
| Q3 25 | 9.1% | 28.4% | ||
| Q2 25 | 7.8% | 25.2% | ||
| Q1 25 | 9.3% | 20.8% | ||
| Q4 24 | 13.7% | -5.6% | ||
| Q3 24 | 8.9% | 17.9% | ||
| Q2 24 | 7.9% | 15.4% | ||
| Q1 24 | 12.7% | 18.0% |
| Q4 25 | 2.93× | — | ||
| Q3 25 | 2.66× | — | ||
| Q2 25 | 1.10× | — | ||
| Q1 25 | 1.83× | — | ||
| Q4 24 | 2.28× | 0.35× | ||
| Q3 24 | 1.98× | — | ||
| Q2 24 | 1.25× | 2.04× | ||
| Q1 24 | 1.51× | 0.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
LBTYA
暂无分部数据
